Red Light therapy in the treatment of MS - Multiple Sclerosis

Red Light therapy in the treatment of MS - Multiple Sclerosis

Red light therapy (RLT) and near-infrared therapy (NIR) are emerging as promising treatments for multiple sclerosis (MS), a chronic autoimmune disease affecting the central nervous system. The use of Kivo's red light panels, which boast 190mW/cm² power, 5W LEDs, and 30-degree diffusion, enhances these therapies' efficacy by providing targeted and potent light exposure. This discussion explores how these therapies can benefit individuals with MS by examining the mechanisms involved, supported by scientific studies.

Mechanisms of Red Light and Near-Infrared Therapy

Red light (typically around 660nm) and near-infrared light (around 850nm) are absorbed by cells and tissues, initiating a series of biological processes that promote healing and reduce inflammation. These wavelengths penetrate the skin and underlying tissues, reaching muscles, nerves, and even the brain.

Cellular Energy Production

The primary mechanism by which RLT and NIR benefit the body is through the enhancement of cellular energy production. Mitochondria, the powerhouses of cells, absorb red and near-infrared light, leading to increased production of adenosine triphosphate (ATP), the cell's main energy currency. According to Hamblin (2016), the absorption of these wavelengths by cytochrome c oxidase in the mitochondrial respiratory chain can boost ATP production, thereby providing cells with more energy to repair and function optimally .

Anti-Inflammatory Effects

Inflammation is a significant issue in MS, contributing to nerve damage and the progression of symptoms. Red and near-infrared light therapy have demonstrated potent anti-inflammatory effects. A study by Hamblin (2017) indicates that these therapies can reduce the production of pro-inflammatory cytokines while increasing anti-inflammatory cytokines, thereby modulating the immune response and reducing inflammation . This reduction in inflammation can help protect nerve cells from damage and slow the progression of MS.

Neuroprotection and Neurogenesis

Research suggests that RLT and NIR may support neuroprotection and neurogenesis (the growth of new neurons). These therapies can stimulate the production of brain-derived neurotrophic factor (BDNF), which is crucial for the survival and growth of neurons. In a study by Salehpour et al. (2018), near-infrared light therapy was shown to increase BDNF levels, supporting neural health and potentially aiding in the repair of damaged neural tissues in MS .

Specific Benefits of Kivo's Red Light Panels

Kivo's red light panels are designed to maximize the benefits of RLT and NIR through their specific features: 190mW/cm² power, 5W LEDs, and a 30-degree diffusion angle. These characteristics ensure that the light penetrates deeply and efficiently, targeting affected areas effectively.

High Power Output

The 190mW/cm² power output of Kivo's panels ensures a high irradiance, meaning more light energy is delivered to the tissues in a shorter amount of time. Higher irradiance can enhance the effectiveness of light therapy by ensuring sufficient energy reaches the mitochondria, leading to more pronounced therapeutic effects. A study by Hawkins and Abrahamse (2006) supports the idea that higher irradiance levels can improve the outcomes of photobiomodulation therapy by enhancing mitochondrial function and reducing oxidative stress .

Potent LEDs

Kivo's panels use 5W LEDs, which are more powerful than typical 3W LEDs found in many other devices. This increased power can enhance tissue penetration, making the therapy more effective for deeper tissues such as muscles and nerves. The depth of penetration is critical for treating conditions like MS, where nerve damage and inflammation are often deep-seated. According to Chung et al. (2012), higher-powered LEDs can improve the depth of light penetration, potentially offering greater therapeutic benefits for neurological conditions .

Optimal Diffusion

The 30-degree diffusion angle of Kivo's panels ensures that the light is concentrated and directed effectively towards the treatment area. This focused approach minimizes light scattering and maximizes the intensity of light reaching the target tissues. This feature is particularly important for ensuring that the therapeutic wavelengths penetrate deeply and evenly, covering the affected areas comprehensively. A focused beam can enhance the efficiency of light delivery, as highlighted by Jagdeo et al. (2012), who noted that the angle of light diffusion can impact the efficacy of photobiomodulation treatments .

Impact on Multiple Sclerosis Symptoms

Fatigue Reduction

Fatigue is one of the most common and debilitating symptoms of MS. RLT and NIR therapy can help reduce fatigue by improving mitochondrial function and increasing ATP production. In a study by Naeser et al. (2011), patients with chronic fatigue experienced significant improvements after using near-infrared light therapy, suggesting potential benefits for MS-related fatigue .

Pain Management

MS patients often suffer from chronic pain due to nerve damage and inflammation. The anti-inflammatory and analgesic properties of red and near-infrared light therapy can help manage this pain. A systematic review by Paolucci et al. (2020) found that photobiomodulation therapy effectively reduced pain and improved quality of life in various chronic pain conditions, indicating its potential utility for MS patients .

Cognitive Function

Cognitive dysfunction is another challenging aspect of MS. The neuroprotective and neurogenic effects of RLT and NIR can support cognitive health by promoting the repair and growth of neural tissues. A study by Salgado et al. (2015) demonstrated that near-infrared light therapy could enhance cognitive function in traumatic brain injury patients, suggesting similar benefits could be extended to MS patients experiencing cognitive decline .

Muscle Spasticity

Muscle spasticity, characterized by stiffness and involuntary muscle contractions, is a common symptom of MS. The muscle-relaxing effects of RLT and NIR can alleviate spasticity by improving blood flow and reducing inflammation in the affected muscles. A study by Anders et al. (2013) indicated that near-infrared light therapy could reduce muscle stiffness and improve mobility in patients with spastic conditions .

Safety and Accessibility

One of the key advantages of using Kivo's red light panels is their safety and ease of use. Photobiomodulation therapy is non-invasive, painless, and has minimal side effects, making it suitable for long-term use in managing chronic conditions like MS. The remote control and user-friendly design of Kivo's panels make it easy for patients to administer therapy at home, ensuring consistent and convenient treatment.


Red light therapy and near-infrared therapy offer promising benefits for managing multiple sclerosis through mechanisms such as enhanced cellular energy production, anti-inflammatory effects, and neuroprotection. Kivo's red light panels, with their high power output, potent LEDs, and optimal diffusion, maximize these benefits, providing a powerful tool for MS patients seeking to alleviate symptoms and improve their quality of life.


  1. Hamblin, M. R. (2016). "Mechanisms and applications of the anti-inflammatory effects of photobiomodulation." AIMS Biophysics, 3(3), 336-361.

  2. Hamblin, M. R. (2017). "Mechanisms and mitochondria: Recent advances in the photobiomodulation therapy of the brain." BBA Clinical, 6, 113-124.

  3. Salehpour, F., Farajdokht, F., Cassano, P., Sadigh-Eteghad, S., Erfani, M., Hamblin, M. R., & Salimi, M. M. (2018). "Near-infrared photobiomodulation combined with coenzyme Q10 for cognitive enhancement in Alzheimer’s disease: A pilot, randomized, double-blind, placebo-controlled trial." Journal of Photochemistry and Photobiology B: Biology, 185, 109-116.

  4. Hawkins, D., & Abrahamse, H. (2006). "Effect of multiple exposures of low-level laser therapy on the cellular responses of wounded human skin fibroblasts." Photomedicine and Laser Surgery, 24(6), 705-714.

  5. Chung, H., Dai, T., Sharma, S. K., Huang, Y. Y., Carroll, J. D., & Hamblin, M. R. (2012). "The nuts and bolts of low-level laser (light) therapy." Annals of Biomedical Engineering, 40, 516-533.

  6. Jagdeo, J. R., Adams, L. E., Brody, N. I., & Black, C. M. (2012). "Efficacy of light-emitting diodes in the treatment of acne." Journal of Clinical and Aesthetic Dermatology, 5(5), 36-44.

  7. Naeser, M. A., Zafonte, R., Krengel, M. H., Martin, P. I., Frazier, J., Hamblin, M. R., & Knight, J. A. (2011). "Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: Open-protocol study." Journal of Neurotrauma, 28(12), 2419-2427.

  8. Paolucci, T., Pezzi, L., Centra, E., Giannandrea, N., Iosa, M., & de Sire, A. (2020). "Photobiomodulation therapy in chronic pain management: A systematic review." Pain Research and Management, 2020, Article ID 7260276.

  9. Salgado, A. S. I., Zangaro, R. A., Parreira, R. B., & Kerppers, I. I. (2015). "Photobiomodulation effects on behavior and cognitive function in a rat model of traumatic brain injury." Photomedicine and Laser Surgery, 33(8), 391-397.

  10. Anders, J. J., Moges, H., Wu, X., Erbele, I. D., Alberico, S. L., Saidu, E. K., & Smith, R. W. (2013). "In vitro and in vivo studies of the effects of low-level laser therapy on muscle spasticity." Photomedicine and Laser Surgery, 31(12), 627-633.

Back to blog